
Creabilis appoints board chairman
pharmafile | June 4, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Catherine Moukheibiras, creabilis
UK, Canterbury-based dermatology firm Creabilis has appointed Catherine Moukheibiras as the chairman of its board of directors.
After an initial career in strategy consulting and investment banking in Boston and London, Moukheibiras has held several roles Europe’s biotech companies.
She was previously chief financial officer of Movetis, a Belgian speciality pharmaceutical company from 2008 to 2010 that was subsequently acquired by Shire.
Moukheibiras is currently a non-executive board member of Ablynx and Zealand Pharma, and a member of the management board of Innate Pharma.
Moukheibiras says: “I am delighted to have been appointed to lead the Creabilis Board at this important time in the Company’s development.”






